| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |